Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,148.98
(
0.68%
)
News Focus
News Focus
Post# of 822911
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jesster64

Send PM Follow Ignore
Followers 23
Posts 2811
Boards Moderated 0
Alias Born 03/22/2021

jesster64

Re: WideEyed post# 789027

Friday, 09/19/2025 11:09:30 PM

Friday, September 19, 2025 11:09:30 PM

Post# of 822911
Serious question. Would trials of combinations with dc-vax first have to be held before any combo can be prescribed after dc-vax approval? While the franchise model makes sense, you can't just prescribe a combo with dc-vax. Combo trials have to be held to check for any side effects or just for effectiveness. So the thought that approval brings on immediate revenue with franchising wouldnt make sense because there is no data for the majority of combos. Am I wrong?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News